Multiple treatmentsof LLO-SK decreased classical precursor Tregs (CD25+FoxP3-),which could have contributed to the limitation of tumor growth inthese groups (Figure , Supporting Information Figure S12)., This evidence concerns the gene FOXP3 and neoplasm.